Identify the most viable market opportunities
Analyze disease burden, unmet need, and addressable patient populations to determine the attractiveness of a given indication.
Assess competitive dynamics to refine strategy
Evaluate competitor trial designs, regulatory approvals, and HTA outcomes to identify differentiation opportunities and anticipate market challenges.
Optimize pricing strategy from the start
Leverage market value assessments and pricing benchmarks to prioritize indications with the strongest reimbursement potential.